National Pension Service Raises Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

National Pension Service increased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 7.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 185,972 shares of the company's stock after acquiring an additional 12,647 shares during the period. National Pension Service owned about 0.23% of IDEXX Laboratories worth $93,957,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of IDXX. Crewe Advisors LLC bought a new stake in IDEXX Laboratories during the first quarter valued at about $26,000. Ridgewood Investments LLC bought a new stake in IDEXX Laboratories during the second quarter valued at about $27,000. Institutional & Family Asset Management LLC bought a new stake in IDEXX Laboratories during the second quarter valued at about $28,000. E Fund Management Hong Kong Co. Ltd. grew its holdings in IDEXX Laboratories by 5,700.0% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 58 shares of the company's stock valued at $29,000 after purchasing an additional 57 shares during the period. Finally, Mowery & Schoenfeld Wealth Management LLC grew its holdings in IDEXX Laboratories by 750.0% during the third quarter. Mowery & Schoenfeld Wealth Management LLC now owns 68 shares of the company's stock valued at $34,000 after purchasing an additional 60 shares during the period. Institutional investors own 87.84% of the company's stock.

IDEXX Laboratories Price Performance

Shares of NASDAQ:IDXX traded up $7.44 during mid-day trading on Wednesday, reaching $423.42. The stock had a trading volume of 1,074,503 shares, compared to its average volume of 728,188. The company has a current ratio of 1.42, a quick ratio of 1.03 and a debt-to-equity ratio of 0.32. The company has a market cap of $34.67 billion, a P/E ratio of 40.83, a price-to-earnings-growth ratio of 3.61 and a beta of 1.36. IDEXX Laboratories, Inc. has a 1 year low of $404.74 and a 1 year high of $583.39. The business's 50 day moving average price is $474.87 and its 200 day moving average price is $485.88.

IDEXX Laboratories (NASDAQ:IDXX - Get Free Report) last posted its earnings results on Thursday, October 31st. The company reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.69 by $0.11. The company had revenue of $975.50 million for the quarter, compared to the consensus estimate of $980.32 million. IDEXX Laboratories had a return on equity of 55.42% and a net margin of 22.53%. The firm's revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the previous year, the business earned $2.53 earnings per share. Research analysts expect that IDEXX Laboratories, Inc. will post 10.45 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have issued reports on IDXX shares. JPMorgan Chase & Co. cut their price target on IDEXX Laboratories from $630.00 to $575.00 and set an "overweight" rating for the company in a report on Friday, October 11th. Stifel Nicolaus dropped their price objective on IDEXX Laboratories from $510.00 to $500.00 and set a "hold" rating for the company in a research note on Thursday, October 10th. BTIG Research started coverage on IDEXX Laboratories in a research note on Thursday, July 25th. They issued a "buy" rating and a $580.00 price objective for the company. Barclays dropped their price objective on IDEXX Laboratories from $570.00 to $481.00 and set an "overweight" rating for the company in a research note on Monday. Finally, StockNews.com lowered IDEXX Laboratories from a "buy" rating to a "hold" rating in a research note on Wednesday, July 10th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $552.38.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.